Skip to main content
Erschienen in: Journal of Cancer Education 2/2013

01.06.2013

Pap Screening Goals and Perceptions of Pain among Black, Latina, and Arab Women: Steps Toward Breaking down Psychological Barriers

verfasst von: Julie W. Gauss, Athur Mabiso, Karen Patricia Williams

Erschienen in: Journal of Cancer Education | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

Understanding women’s psychological barriers to getting Papanicolaou (Pap) screening has potential to impact cancer disparities. This study examined pain perceptions of Pap testing among black, Latina, and Arab women and goal setting to receive Pap tests. Data on 420 women, in a longitudinal study, were analyzed using Chi-square tests of differences and generalized linear mixed models. At baseline, 30.3 % of black and 35.5 % of Latina women perceived Pap tests to be very painful compared to 24.2 % of Arab women. Perceptions of pain influenced goal settings, such as scheduling a first ever Pap test (odds ratio = 0.58, 95 % confidence interval 0.14–0.94). Immediately following the intervention, women’s perception that Pap tests are very painful significantly declined (P value <0.001) with Arab and black women registering the greatest improvements (20.3 and 17.3 % reduction, respectively, compared to 8.4 % for Latina). Having the perception that the Pap test is very painful significantly reduces the likelihood of black, Latina, and Arab women setting the goal to schedule their first ever Pap test. Latina women are the least likely to improve their perception that the Pap test is very painful, though national statistics show they have the highest rates of morbidity and mortality from cervical cancer. These findings are instructive for designing tailored interventions to break down psychological barriers to Pap screening among underserved women.
Literatur
2.
Zurück zum Zitat Jemal A, Thun M, Ries L et al (2008) Annual report to the nation on the status of cancer, 1975–2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst 100(23):1672–1694PubMedCrossRef Jemal A, Thun M, Ries L et al (2008) Annual report to the nation on the status of cancer, 1975–2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst 100(23):1672–1694PubMedCrossRef
5.
Zurück zum Zitat Hakama M, Miller AB, Day NE (eds) (1986) Screening for cancer of the uterine cervix: from the IARC working group on cervical cancer screening and the UICC project group on the evaluation of screening programmes for cancer. Oxford University Press, New York Hakama M, Miller AB, Day NE (eds) (1986) Screening for cancer of the uterine cervix: from the IARC working group on cervical cancer screening and the UICC project group on the evaluation of screening programmes for cancer. Oxford University Press, New York
7.
Zurück zum Zitat Hoyo C, Yarnall KSH, Skinner CS et al (2005) Pain predicts non-adherence to pap smear screening among middle-aged African American women. Preventive Medicine 41:439–445PubMedCrossRef Hoyo C, Yarnall KSH, Skinner CS et al (2005) Pain predicts non-adherence to pap smear screening among middle-aged African American women. Preventive Medicine 41:439–445PubMedCrossRef
11.
Zurück zum Zitat Jennings-Dozier K (1999) Predicting intentions to obtain a Pap smear among African American and Latina Women: Testing the theory of planned behavior. Nurs Res 48(4):198–205PubMedCrossRef Jennings-Dozier K (1999) Predicting intentions to obtain a Pap smear among African American and Latina Women: Testing the theory of planned behavior. Nurs Res 48(4):198–205PubMedCrossRef
12.
Zurück zum Zitat de la Cruz GP, Brittingham A. The Arab population: census 2000 brief. December 2003, US Census Bureau de la Cruz GP, Brittingham A. The Arab population: census 2000 brief. December 2003, US Census Bureau
14.
Zurück zum Zitat Matin M, LeBaron S (2004) Attitudes toward cervical cancer screening among Muslim women: a pilot study. Women & Health 39(3):63–77CrossRef Matin M, LeBaron S (2004) Attitudes toward cervical cancer screening among Muslim women: a pilot study. Women & Health 39(3):63–77CrossRef
15.
Zurück zum Zitat Salman K (2012) Health beliefs and practices related to cancer screening among Arab Muslim women in an urban community. Health Care for Women International 33(1):45–74PubMedCrossRef Salman K (2012) Health beliefs and practices related to cancer screening among Arab Muslim women in an urban community. Health Care for Women International 33(1):45–74PubMedCrossRef
17.
Zurück zum Zitat Williams KP, Mullan PB, Todem D (2009) Moving from theory to practice: implementing the Kin KeeperSM Cancer Prevention model. Health Educ Res 24:343–56PubMedCrossRef Williams KP, Mullan PB, Todem D (2009) Moving from theory to practice: implementing the Kin KeeperSM Cancer Prevention model. Health Educ Res 24:343–56PubMedCrossRef
18.
Zurück zum Zitat Williams KP, Reiter P, Mabiso A, Maurer J, Paskett E (2009) Family History of cancer predicts Papanicolaou screening behavior for African American and White women. Cancer 115(1):179–189PubMedCrossRef Williams KP, Reiter P, Mabiso A, Maurer J, Paskett E (2009) Family History of cancer predicts Papanicolaou screening behavior for African American and White women. Cancer 115(1):179–189PubMedCrossRef
19.
Zurück zum Zitat Mandelblatt JS, Gold K, O'Malley AS et al (1999) Breast and Cervix cancer screening among multiethnic women: role of age, health, and source of care. Preventive Medicine 28(4):418–425PubMedCrossRef Mandelblatt JS, Gold K, O'Malley AS et al (1999) Breast and Cervix cancer screening among multiethnic women: role of age, health, and source of care. Preventive Medicine 28(4):418–425PubMedCrossRef
20.
Zurück zum Zitat Harlan LC, Bernstein AB, Kessler LG (1991) Cervical cancer screening: who is not screened and why? Am J Public Health 81(7):885–890PubMedCrossRef Harlan LC, Bernstein AB, Kessler LG (1991) Cervical cancer screening: who is not screened and why? Am J Public Health 81(7):885–890PubMedCrossRef
21.
Zurück zum Zitat Skrondal A, Rabe-Hesketh S (2009) Prediction in multilevel generalized linear models. Journal of the Royal Statistical Society, Series A 172:659–687 Skrondal A, Rabe-Hesketh S (2009) Prediction in multilevel generalized linear models. Journal of the Royal Statistical Society, Series A 172:659–687
22.
Zurück zum Zitat Skrondal A, Rabe-Hesketh S (2004) Generalized latent variable modeling: multilevel, longitudinal, and structural equation models. Chapman & Hall/CRC, Boca Raton, FLCrossRef Skrondal A, Rabe-Hesketh S (2004) Generalized latent variable modeling: multilevel, longitudinal, and structural equation models. Chapman & Hall/CRC, Boca Raton, FLCrossRef
23.
Zurück zum Zitat Raudenbush SW, Bryk AS (2002) Hierarchical linear models: applications and data analysis methods, 2nd edn. Sage, Newbury Park, CA Raudenbush SW, Bryk AS (2002) Hierarchical linear models: applications and data analysis methods, 2nd edn. Sage, Newbury Park, CA
24.
Zurück zum Zitat SAS Institute Inc., 2008. SAS/STAT® 9.2 User's guide. Cary, NC: SAS Institute Inc. SAS Institute Inc., 2008. SAS/STAT® 9.2 User's guide. Cary, NC: SAS Institute Inc.
25.
Zurück zum Zitat Percac-Lima S, Aldrich LS, Gamba MA et al (2011) Barriers to follow-up of an abnormal Pap smear in Latina women referred for colposcopy. J Gen Intern Med 25(11):1198–1204CrossRef Percac-Lima S, Aldrich LS, Gamba MA et al (2011) Barriers to follow-up of an abnormal Pap smear in Latina women referred for colposcopy. J Gen Intern Med 25(11):1198–1204CrossRef
Metadaten
Titel
Pap Screening Goals and Perceptions of Pain among Black, Latina, and Arab Women: Steps Toward Breaking down Psychological Barriers
verfasst von
Julie W. Gauss
Athur Mabiso
Karen Patricia Williams
Publikationsdatum
01.06.2013
Verlag
Springer-Verlag
Erschienen in
Journal of Cancer Education / Ausgabe 2/2013
Print ISSN: 0885-8195
Elektronische ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-012-0441-1

Weitere Artikel der Ausgabe 2/2013

Journal of Cancer Education 2/2013 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.